-- Core Scientific（CORZ）は、完全子会社であるCore Scientific Finance Iが、2031年満期、利率7.750%の優先担保付社債33億ドルを、元本比99.250%で発行したと発表した。 Core Scientificは水曜遅く、この子会社が調達資金を債務返済準備金口座に充当し、残額を親会社に分配する予定だと述べた。また、純調達資金の一部を、364日融資枠からの返済遅延分に充当する意向も示した。 この社債は機関投資家向けに私募形式で販売される。発行は5月6日に完了する見込み。 Core Scientificの株価は、木曜のプレマーケット取引で1.3%下落した。
Price: $20.91, Change: $-0.28, Percent Change: -1.32%
(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.
Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.
Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.